Saturday 17 October 2026 Export TRDA’s income statement to Excel — free account

Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $25.4 million, down 87.9% from fiscal 2024. In the quarter to June 2026, revenue fell 54.0%, EPS grew 2.88% and free cash flow fell 9.10%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.37 0.41 −8.58%

Follow TRDA

Alert me

Market cap: $186.1M
P/E: 0.0×
Fwd P/E: −1.6×
Dividend yield: —
F-score: 3/9
Altman Z: 2.15
Beneish M: −6.07
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	2	2	3	—	+8 more TTM periods Free account
ROE Full definition →	(54.09%)	(48.28%)	(39.13%)	(27.11%)
ROA Full definition →	(44.35%)	(40.42%)	(31.81%)	(21.39%)
ROIC Full definition →	(1,060.24%)	(697.14%)	(1,009.37%)	(547.44%)
Return on Tangible Assets Full definition →	(76.38%)	(65.35%)	(49.72%)	(32.06%)
Average Days of Receivables Full definition →	63.56	50.06	16.90	7.10
Free Cash Flow per Share Full definition →	(3.18)	(3.15)	(3.13)	(3.13)
Free Cash Flow Full definition →	(134.35)	(131.64)	(129.55)	(129.80)
Capital Expenditures Full definition →	0.32	0.06	(1.04)	(1.88)
Other line items
Cash ROIC Full definition →	(29.44%)	(25.04%)	(21.50%)	(19.44%)
Accounts Receivable Turnover Full definition →	4.70	4.05	10.47	32.39
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.01	0.01	(0.01)	(0.03)
Research and Development Expense of Revenue Full definition →	3,003.44%	2,496.50%	559.65%	230.36%
Selling, General and Administrative Expense of Revenue Full definition →	863.64%	712.79%	161.48%	67.23%
Share Based Compensation of Revenue Full definition →	413.32%	335.76%	77.14%	32.43%
Operating CF/Net income Full definition →	0.81	0.79	0.89	1.24
Depreciation/Fixed assets Full definition →	0.24	0.17	0.06	(0.16)
Capex/Depreciation Full definition →	0.23	0.05	(2.45)	1.40
Revenue per Share Full definition →	0.11	0.14	0.61	1.48
Operating CF per Share Full definition →	(3.19)	(3.15)	(3.11)	(3.08)
Capex per Share Full definition →	0.01	0.00	(0.03)	(0.05)
Capex to Sales Full definition →	(0.07)	(0.01)	0.04	0.03

Show all line items

Columns are period end dates

Stockrow Weekly